Growth Metrics

Travere Therapeutics (TVTX) Finished Goods (2016 - 2018)

Historic Finished Goods for Travere Therapeutics (TVTX) over the last 4 years, with Q1 2018 value amounting to $1.4 million.

  • Travere Therapeutics' Finished Goods fell 1117.46% to $1.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $1.4 million, marking a year-over-year decrease of 1117.46%. This contributed to the annual value of $1.9 million for FY2017, which is 2859.06% up from last year.
  • As of Q1 2018, Travere Therapeutics' Finished Goods stood at $1.4 million, which was down 1117.46% from $1.9 million recorded in Q4 2017.
  • Travere Therapeutics' Finished Goods' 5-year high stood at $2.5 million during Q2 2016, with a 5-year trough of $1.4 million in Q1 2018.
  • Moreover, its 4-year median value for Finished Goods was $1.7 million (2017), whereas its average is $1.9 million.
  • Its Finished Goods has fluctuated over the past 5 years, first plummeted by 3368.94% in 2016, then soared by 2859.06% in 2017.
  • Travere Therapeutics' Finished Goods (Quarter) stood at $2.2 million in 2015, then plummeted by 33.69% to $1.5 million in 2016, then grew by 28.59% to $1.9 million in 2017, then dropped by 26.98% to $1.4 million in 2018.
  • Its last three reported values are $1.4 million in Q1 2018, $1.9 million for Q4 2017, and $1.6 million during Q1 2017.